Design of a Phase III immunogenicity and safety study evaluating two-dose regimens of 9-valent human papillomavirus (9vHPV) vaccine with extended dosing intervals.
Sign Up to like & getrecommendations! Published in 2021 at "Contemporary clinical trials"
DOI: 10.1016/j.cct.2021.106403
Abstract: HPV vaccines are widely licensed as two-dose regimens, 6-12 months apart, for adolescents. Extended intervals between doses may be necessary due to resource constraints or vaccination program disruption. This international, multicenter, open-label study (NCT04708041) will evaluate… read more here.
Keywords: two dose; study; dose regimens; 9vhpv vaccine ... See more keywords
Neutralizing antibody activity against the B.1.617.2 (delta) variant 8 months after two-dose vaccination with BNT162b2 in health care workers
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Microbiology and Infection"
DOI: 10.1016/j.cmi.2022.01.011
Abstract: Objectives Humoral immunity wanes over time after two-dose BNT162b2 vaccination. Emerging variants of concern, such as the B.1.617.2 (delta) variant, are increasingly responsible for breakthrough infections due to their higher transmissibility and partial immune escape.… read more here.
Keywords: time; delta variant; vaccination; 617 delta ... See more keywords
Understanding the Two-Dose HPV Vaccine Schedule.
Sign Up to like & getrecommendations! Published in 2018 at "Nursing for women's health"
DOI: 10.1016/j.nwh.2018.02.004
Abstract: Recent advances in human papillomavirus (HPV) science have led to updates to national HPV vaccine recommendations. This column takes a second look at two recent studies that provide evidence to support the current two-dose HPV… read more here.
Keywords: dose hpv; understanding two; two dose; hpv vaccine ... See more keywords
Cost-effectiveness of the introduction of two-dose bi-valent (Cervarix) and quadrivalent (Gardasil) HPV vaccination for adolescent girls in Bangladesh.
Sign Up to like & getrecommendations! Published in 2019 at "Vaccine"
DOI: 10.1016/j.vaccine.2019.10.037
Abstract: BACKGROUND Cervical cancer is one of the most prevalent cancers in women caused by the human papillomavirus (HPV) that leads to a substantial disease burden for health systems. Prevention through vaccination can significantly reduce the… read more here.
Keywords: cost effectiveness; two dose; cost; hpv vaccination ... See more keywords
Completion of the two-dose recombinant zoster vaccine series in adults 50 years and older.
Sign Up to like & getrecommendations! Published in 2021 at "Vaccine"
DOI: 10.1016/j.vaccine.2020.12.076
Abstract: BACKGROUND In 2017, a new adjuvanted recombinant zoster vaccine (RZV) was recommended for adults ≥50 years as two-dose series 2-6 months apart. We evaluated two-dose RZV completion and factors associated with completion. METHODS The study included Kaiser… read more here.
Keywords: first dose; two dose; completion; series ... See more keywords
Immune persistence induced by two-dose BBIBP-CorV vaccine with different intervals, and immunogenicity and safety of a homologous booster dose in high-risk occupational population
Sign Up to like & getrecommendations! Published in 2022 at "Expert Review of Vaccines"
DOI: 10.1080/14760584.2022.2141711
Abstract: ABSTRACT Background The immune persistence of neutralizing antibodies elicited by BBIBP-CorV vaccines on day 0–14, 0–21 and 0–28 schedule, and the immunogenicity and safety of a homologous booster dose after different priming vaccination regimens is… read more here.
Keywords: persistence; booster dose; bbibp corv; homologous booster ... See more keywords
Immunogenicity of the BNT162b2 COVID-19 vaccine as a third dose (booster) following two doses of different primary series regimens in Thailand
Sign Up to like & getrecommendations! Published in 2022 at "Pathogens and Global Health"
DOI: 10.1080/20477724.2022.2108646
Abstract: Several countries have achieved high two-dose COVID-19 vaccination coverage but have been unable to control the spread of SARS-CoV-2. A third dose (booster) has been recommended worldwide to achieve better protection against the newly emerged… read more here.
Keywords: two dose; booster; primary series; vaccine ... See more keywords
Waning of humoral immunity depending on the types of COVID-19 vaccine
Sign Up to like & getrecommendations! Published in 2023 at "Infectious Diseases"
DOI: 10.1080/23744235.2023.2165707
Abstract: Abstract Background There are limited data on the rates of the waning of antibody levels after two-dose and booster vaccination according to the different platforms of COVID-19 vaccines. Methods We enrolled healthcare workers (HCWs) in… read more here.
Keywords: mrna 1273; vaccination; two dose; booster ... See more keywords
SARS-CoV-2 mRNA Vaccine Effectiveness in Health Care Workers by Dosing Interval and Time Since Vaccination: Test-Negative Design, British Columbia, Canada
Sign Up to like & getrecommendations! Published in 2022 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofac178
Abstract: Abstract Background One- and two-dose mRNA vaccine effectiveness (VE) estimates against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection by dosing interval and time since vaccination were assessed among healthcare workers (HCWs) in publicly funded… read more here.
Keywords: vaccine effectiveness; vaccination; test; two dose ... See more keywords
Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the Congo
Sign Up to like & getrecommendations! Published in 2022 at "BMJ Open"
DOI: 10.1136/bmjopen-2021-055596
Abstract: Introduction Ebola virus disease (EVD) continues to be a significant public health problem in sub-Saharan Africa, especially in the Democratic Republic of the Congo (DRC). Large-scale vaccination during outbreaks may reduce virus transmission. We established… read more here.
Keywords: virus disease; trial; two dose; ebola virus ... See more keywords
Introduction of Two-Dose Mumps-Containing Vaccine into Routine Immunization Schedule in Quzhou, China, Using Cox-Proportional Hazard Model
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Immunology Research"
DOI: 10.1155/2021/5990417
Abstract: Mumps is a vaccine-preventable disease caused by the mumps virus, but the incidence of mumps has increased among the children who were vaccinated with one-dose measles-mumps-rubella (MMR) in recent years. In this study, we analyzed… read more here.
Keywords: hazard; two dose; immunization; cox proportional ... See more keywords